From Sovereignty to Technological Leadership. New Benchmarks for Russian Pharmaceuticals

The Russian pharmaceutical industry currently faces new challenges. Organizations working in the industry have set the ambitious goal of not only achieving technological self-sufficiency, but becoming leaders in their field. It is not just a matter of competitiveness, but about the desire to rise to the top of the world’s technological rankings in order to have the potential to predict and determine the future of the industry. To achieve these goals, extensive work is being carried out today to phase out imports, including the development of the bioeconomy, small chemistry, and other industries whose products are not exclusively medical. A key focus is to ensure an innovative scenario for the industry’s development based on breakthrough achievements in genetics and biomedicine. Given the high level of global competition, a determining factor for success is the accelerated introduction of artificial intelligence and modern information technologies that help improve the process of developing new drugs, optimize clinical trials, and enhance the accuracy of diagnostics. Investing in these technologies will enable companies to not only strengthen their positions on the domestic market, but to also take their place among the leaders of the global pharmaceutical sector. What challenges does the Russian pharmaceutical industry face today? What results have been achieved as part of the implementation of the Pharma 2030 Strategy? How can the industry adapt to rapidly changing market conditions and incorporate advanced management practices? What specific benefits will companies receive thanks to the introduction of information technologies? What regulatory decisions and support tools can ensure the implementation of import substitution roadmaps? What government strategies promote the industry’s innovative development in the context of the new national project ‘New Health Preservation Technologies’? What breakthroughs in medical science and high-tech solutions will create a foundation for the Russian pharmaceutical industry to achieve a new level of competitiveness and technological leadership?